- call +1-201-465-4211
- email sales@mrinsights.biz
Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity directed against gastric glandular cell. Symptoms include stomach pain, loss of appetite, nausea, unexpected weight loss, iron deficiency anemia. There is a high chance for the development of pernicious anemia in autoimmune atrophic gastritis Individual due to the loss of anti-intrinsic antibodies and parietal cell mass. Atrophic gastritis associated with H. Pylori are at high risk of developing gastric carcinoma and is frequently asymptomatic. Individuals associated with chronic atrophic gastritis develop hypergastrinemia and low gastric acid output which may lead to carcinoid tumors and enterochromaffin-like cell hyperplasia. Atrophic gastritis develops at childhood and if, it is left untreated atrophic gastritis progress throughout the lifespan. Treatment mainly includes antibiotics for eliminating H. Pylori bacteria. Symptomatic treatment includes vitamin B-12 injections. Proton pump inhibitors used to control the acidity of the stomach. Autoimmune atrophic gastritis associated with gastric polyps, pernicious anemia, and adenocarcinoma. Atrophic gastritis diagnosed by low levels of B-12, low levels of pepsinogen, high levels of gastrin and intrinsic factors.
Scope of the Report:
This report studies the Atrophic Gastritis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Atrophic Gastritis Treatment market by product type and applications/end industries.
Atrophic gastritis is associated with loss of gastric gland and is a progressive condition with the replacement of metaplasia. It is asymptomatic and associated with large complications like gastric carcinoma, hyperplasia, hypergastrinemia, increased risk of heart attack in elderly. The frequency of atrophic gastritis is unknown due to it is mostly asymptomatic. Atrophic gastritis is extremely common and is highly prevalent in different parts of the globe. In atrophic gastritis, eradication of H. Pylori is highly complicated, and it requires follow-up for several years. Eradication of H. Pylori reduces the risk of developing cancers in late stages. Mortality and morbidity associated with atrophic gastritis are depended on underlying complications of diseases. Atrophic gastritis requires a continuous management because recurrence of illness is high. All these factors act as a driver in the robust growth of the atrophic gastritis treatment market.
The global Atrophic Gastritis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Atrophic Gastritis Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Takeda Pharmaceutical Company Limited
PERNIX Therapeutics
Perrigo Pharmaceutical
Teva Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Coating Agents
Antibiotics
Vitamin B-12
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Atrophic Gastritis Treatment Market Overview
1.1 Product Overview and Scope of Atrophic Gastritis Treatment
1.2 Classification of Atrophic Gastritis Treatment by Types
1.2.1 Global Atrophic Gastritis Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Atrophic Gastritis Treatment Revenue Market Share by Types in 2017
1.2.3 Coating Agents
1.2.4 Antibiotics
1.2.5 Vitamin B-12
1.3 Global Atrophic Gastritis Treatment Market by Application
1.3.1 Global Atrophic Gastritis Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Pharmacies
1.4 Global Atrophic Gastritis Treatment Market by Regions
1.4.1 Global Atrophic Gastritis Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Atrophic Gastritis Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Takeda Pharmaceutical Company Limited
2.1.1 Business Overview
2.1.2 Atrophic Gastritis Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Takeda Pharmaceutical Company Limited Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 PERNIX Therapeutics
2.2.1 Business Overview
2.2.2 Atrophic Gastritis Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 PERNIX Therapeutics Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Perrigo Pharmaceutical
2.3.1 Business Overview
2.3.2 Atrophic Gastritis Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Perrigo Pharmaceutical Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva Pharmaceutical
2.4.1 Business Overview
2.4.2 Atrophic Gastritis Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Pharmaceutical Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Atrophic Gastritis Treatment Market Competition, by Players
3.1 Global Atrophic Gastritis Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Atrophic Gastritis Treatment Players Market Share
3.2.2 Top 10 Atrophic Gastritis Treatment Players Market Share
3.3 Market Competition Trend
4 Global Atrophic Gastritis Treatment Market Size by Regions
4.1 Global Atrophic Gastritis Treatment Revenue and Market Share by Regions
4.2 North America Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
5 North America Atrophic Gastritis Treatment Revenue by Countries
5.1 North America Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
5.2 USA Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
6 Europe Atrophic Gastritis Treatment Revenue by Countries
6.1 Europe Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
6.2 Germany Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
6.4 France Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Atrophic Gastritis Treatment Revenue by Countries
7.1 Asia-Pacific Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
7.2 China Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
7.5 India Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
8 South America Atrophic Gastritis Treatment Revenue by Countries
8.1 South America Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
8.2 Brazil Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Atrophic Gastritis Treatment by Countries
9.1 Middle East and Africa Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
10 Global Atrophic Gastritis Treatment Market Segment by Type
10.1 Global Atrophic Gastritis Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Atrophic Gastritis Treatment Market Forecast by Type (2018-2023)
10.3 Coating Agents Revenue Growth Rate (2013-2023)
10.4 Antibiotics Revenue Growth Rate (2013-2023)
10.5 Vitamin B-12 Revenue Growth Rate (2013-2023)
11 Global Atrophic Gastritis Treatment Market Segment by Application
11.1 Global Atrophic Gastritis Treatment Revenue Market Share by Application (2013-2018)
11.2 Atrophic Gastritis Treatment Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Drug Stores Revenue Growth (2013-2018)
11.6 Online Pharmacies Revenue Growth (2013-2018)
12 Global Atrophic Gastritis Treatment Market Size Forecast (2018-2023)
12.1 Global Atrophic Gastritis Treatment Market Size Forecast (2018-2023)
12.2 Global Atrophic Gastritis Treatment Market Forecast by Regions (2018-2023)
12.3 North America Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
12.6 South America Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Atrophic Gastritis Treatment Picture
Table Product Specifications of Atrophic Gastritis Treatment
Table Global Atrophic Gastritis Treatment and Revenue (Million USD)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
